Biomea Fusion Q2 EPS $(1.03) Beats $(1.07) Estimate
Portfolio Pulse from Benzinga Newsdesk
Biomea Fusion (NASDAQ:BMEA) reported Q2 losses of $(1.03) per share, beating the analyst consensus estimate of $(1.07) by 3.74%. This represents a 47.14% increase in losses compared to $(0.70) per share from the same period last year.
July 31, 2024 | 9:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Biomea Fusion reported Q2 losses of $(1.03) per share, beating the analyst consensus estimate of $(1.07) by 3.74%. However, the losses increased by 47.14% compared to the same period last year.
While Biomea Fusion's Q2 EPS beat analyst estimates, the significant year-over-year increase in losses may concern investors. The mixed results could lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100